Roger Dansey - 20 Apr 2023 Form 4 Insider Report for Kronos Bio, Inc. (KRON)

Role
Director
Signature
/s/ Allison Frisbee, Attorney-in-Fact
Issuer symbol
KRON
Transactions as of
20 Apr 2023
Transactions value $
$0
Form type
4
Date filed
24 Apr 2023, 16:22
Previous filing
19 Apr 2023
Next filing
16 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRON Director Stock Option (Right to Buy) Award $0 +68K $0.00 68K 20 Apr 2023 Common Stock 68K $1.28 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall vest in three equal annual installments following the date of grant.